MIRA INFORM REPORT

 

 

Report Date :           

13.01.2012

 

IDENTIFICATION DETAILS

 

Name :

ARAB COMPANY FOR PHARMA & MEDICAL PLANT (MEPACO

 

 

Registered Office :

Emarat Misr Lil Tameer, Maskin Sheraton, 3rd Floor, Commercial Centre, Information Centre Street, Cairo

 

 

Country :

Egypt

 

 

Financials (as on) :

31.12.2010

 

 

Date of Incorporation :

03.11.1984

 

 

Com. Reg. No.:

866, Cairo

 

 

Legal Form :

Egyptian Joint Stock Company

 

 

Line of Business :

Manufacturers of pharmaceuticals and medicines

 

 

No. of Employees :

720

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

US$ 1,500,000

 

 

Status :

Good

 

 

Payment Behaviour :

No Complaints

 

 

Litigation :

Clear

 

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – September 30th, 2011

 

Country Name

Previous Rating

                   (30.06.2011)                  

Current Rating

(30.09.2011)

Egypt

a2

a2

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

SUMMARY

 

Company Name                                     : ARAB COMPANY FOR PHARMA & MEDICAL PLANT (MEPACO)

Country of Origin                                    : Egypt

Legal Form                                            : Egyptian Joint Stock Company

Registration Date                                   : 3rd November 1984

Commercial Registration Number            : 866, Cairo

Tax Card Number                                   : 100-167-993

Issued Capital                                        : £E 43,000,000

Paid up Capital                                      : £E 43,000,000

Total Workforce                                     : 720

Activities                                               : Manufacturers of pharmaceuticals and medicines.

Financial Condition                                 : Good

Payments                                             : Nothing detrimental uncovered

Operating Trend                                     : Steady

Recommended Credit Limit                     : US$ 1,500,000

 

COMPANY NAME

 

ARAB COMPANY FOR PHARMA & MEDICAL PLANT (MEPACO)

 

 

company ADDRESS

 

Registered & Physical Address

Location            : Emarat Misr Lil Tameer, Maskin Sheraton, 3rd Floor, Commercial Centre

Street               : Information Centre Street

Town                 : Cairo

Country             : Egypt

Telephone         : (20-2) 22673175 / 22672761 / 22673176

Facsimile          : (20-2) 22674934 / 22672779

Email                : mepaco@mepaco-pharma.net

 

Premises

Subject operates from a large suite of offices that are rented and located in the Central Business Area of Cairo.

 

Branch Office (s)

 

     Location                                                                                          Description

 

·       21 Mostafa Kamel Street, Flat 33                                                       Office premises

Alexandria

     Tel: (20-3) 5457140

     Fax: (20-3) 5457140

 

·       Enshas El Raml                                                                                Factory premises

Sharkeya

Tel: (20-55) 2820406 / 2822711 / 2822480 / 2821863

       Fax: (20-55) 2822690

 

·       Abu Sultan Fayed                                                                             Factory premises

Ismailia

Tel: (20-64) 3400360

Fax: (20-64) 3400876

 

 

KEY PRINCIPALS

 

     Name                                                                                              Position

 

·       Dr Ahmed Saeed El Kilani                                                                  Chairman

 

·       Mokhtar Bishr                                                                                   Technical Manager

 

·       Dr Sanaa Shawki                                                                              Business Development Manager

 

·       Dr Hoda Hanafi                                                                                  Marketing Manager

 

·       Dr Abeer El Ghamry                                                                          Export Manager

 

·       Sherif Fekry                                                                                      Sales Manager

 

·       Mahmoud Abd El Aziz                                                                       Finance Manager

 

·       Dr Fatma Daood                                                                                Production Manager

 

·       Dr Amal Affifi                                                                         Quality Control Manager

 

·       Ahmed Raafat                                                                                   Purchasing Manager

 

·       Abdullah Marzook                                                                             Warehouse Manager

 

 

LEGAL FORM & OWNERS

 

Date of Establishment  : 3rd November 1984

 

Legal Form                  : Egyptian Joint Stock Company

 

Commercial Reg. No.  : 866, Cairo

 

Tax Card No.               : 100-167-993

 

Issued Capital              : £E 43,000,000

 

Paid up Capital            : £E 43,000,000

 

Name of Shareholder (s)                                                        Percentage

 

·       ACDIMA                                                                               67.17%

Cairo

 

·       United Bank                                                                          17.28%

     Cairo

 

·       Medical Holding Co                                                                 7.82%

Cairo

 

·       Memphis Co                                                                           7.82%

     Cairo

 

 

OPERATIONS

 

Activities: Engaged in the manufacture of pharmaceuticals and medicines.

 

Import Countries: Germany, United Kingdom, China and the United States of America.

 

Export Countries: Kuwait, Qatar, Saudi Arabia, Yemen, Jordan, Iraq, Lebanon, Kenya and Mali.

 

Operating Trend: Steady

 

Subject has a workforce of approximately 720 employees.

 

 

FINANCIAL DATA

 

Financial highlights provided by local sources are given below:

 

Currency: Egyptian Pounds (£E)

 

                                                Year Ending 31/12/09:                Year Ending 31/12/10:

 

Total Sales                                £E 86,000,000                           £E 98,500,000

 

Local sources consider subject’s financial condition to be Good.

 

The above financial figures are based on estimations by our local sources.

 

 

BANKERS

 

·       National Bank of Egypt

24 Sherif Street

     Cairo

     Tel: (20-2) 33924175

     Fax: (20-2) 33924143

     Acc No. 11003420007

 

 

PAYMENT HISTORY

 

No complaints regarding subject’s payments have been reported.

 

 

GENERAL COMMENTS

 

During the course of this investigation nothing detrimental was uncovered regarding subject’s operating history or the manner in which payments are fulfilled. As such the company is considered to be a fair trade risk.

 

 

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.51.83

UK Pound

1

Rs.79.42

Euro

1

Rs.65.90

 

 

RATING EXPLANATIONS

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

----

NB

New Business

----

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.